Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 13,242	$ 6,841
Short-term investments	447	252
Accounts receivable (net of allowance for doubtful accounts of $89 in 2024 and $88 in 2023)	10,278	10,349
Inventories (excludes inventories of $4,193 in 2024 and $3,348 in 2023 classified in Other assets - see Note 7)	6,109	6,358
Other current assets	8,706	8,368
Total current assets	38,782	32,168
Investments	463	252
Property, Plant and Equipment (at cost)
Land	307	326
Buildings	16,360	14,966
Machinery, equipment and office furnishings	18,283	17,763
Construction in progress	7,984	8,262
Property, plant and equipment (at cost)	42,934	41,317
Less: accumulated depreciation	19,155	18,266
Property, plant and equipment, net	23,779	23,051
Goodwill	21,668	21,197
Other Intangibles, Net	16,370	18,011
Other Assets	16,044	11,996
Total Assets	117,106	106,675
Current Liabilities
Loans payable and current portion of long-term debt	2,649	1,372
Trade accounts payable	4,079	3,922
Accrued and other current liabilities	15,694	15,766
Income taxes payable	3,914	2,649
Dividends payable	2,084	1,985
Total current liabilities	28,420	25,694
Long-Term Debt	34,462	33,683
Deferred Income Taxes	1,387	871
Other Noncurrent Liabilities	6,465	8,792
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2024 and 2023	1,788	1,788
Other paid-in capital	44,704	44,509
Retained earnings	63,069	53,895
Accumulated other comprehensive loss	(4,945)	(5,161)
Stockholders' equity before deduction for treasury stock	104,616	95,031
Less treasury stock, at cost: 1,049,466,187 shares in 2024 and 1,045,470,249 shares in 2023	58,303	57,450
Total Merck & Co., Inc. stockholders’ equity	46,313	37,581
Noncontrolling Interests	59	54
Total equity	46,372	37,635
Total Liabilities and Equity	$ 117,106	$ 106,675